Press Release   -

Central Venous Catheter Market to Reach USD 6.01 Billion by 2035

According to analysts at Vantage Market Research, the Global Central Venous Catheter Market size is worth USD 3.05 Billion in 2024 and is projected to reach USD 6.01 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 6.35% from 2024 to 2035. Key trends of market include technological advancement, growing number of accidents and the rise in patients requiring critical care, expansion of Home-Based care, and adoption of coated catheters. 

Market Overview

The growing number of accidents and the rise in patients requiring critical care have significantly contributed to the expansion of the central venous catheter industry. Additionally, the increasing prevalence of kidney diseases and the rising number of dialysis patients are driving the growth of the Central Venous Catheter Market. For example, in 2020, over 562,000 Americans were undergoing dialysis, according to the American Kidney Fund. Since central venous catheters are commonly used in dialysis procedures, the growing demand for hemodialysis directly fuels the market’s growth.

The demand for central venous catheters is not only growing in developed nations but is also increasing in emerging markets like China, Brazil, and India. This demand is driven by factors such as rising hospital admissions, an increase in surgical procedures, and greater healthcare spending. Additionally, the rising frequency of accidents and emergency health conditions is expected to further propel market growth. However, issues like product recalls from manufacturers pose challenges to the overall growth of the market.

ICU Medical Acquires Smiths Medical, Expanding Portfolio in Infusion and Vascular Access Solutions

• In January 2022, ICU Medical Inc. finalized the acquisition of Smiths Medical, a division of Smiths Group plc. The acquired portfolio encompasses syringe and ambulatory infusion systems, vascular access solutions, and critical care products

Key Takeaways from the Report

• In 2024, North America dominated the market with 44.3% market share. Market is driven by presence of advanced healthcare systems, and robust adoption of cutting-edge medical devices
• In 2024, based on the Product Type, the Non-Tunneled Catheters category accounted for significant market share of 45.5%. The segment growth is driven by the rising prevalence of kidney disorders and an increase in accident-related cases
• Based on the Property, the Non-Antimicrobial Catheters category accounted for significant market share if 62.3% in 2024. The segment is driven by widespread use of traditional catheters, which continue to be favored in many clinical settings due to their lower cost compared to antimicrobial-coated alternatives
• By Design, Double Lumen segment dominated the market in 2024 with significant market share of 35.5%. Double Lumen design is preferred for its versatility and ability to facilitate multiple medical treatments
• In 2024, by End-User, Hospitals dominated the market with market share of 60.5%. The high demand for central venous catheters in hospital settings is driven by the increasing number of surgeries, emergency procedures, and treatments for chronic diseases

Top Companies

• Medtronic plc
• Becton, Dickinson and Company
• Rex Medical LLC.
• ICU Medical Inc.
• Vygon
• Merit Medical Systems Inc.
• Teleflex Incorporated
• AngioDynamics Inc.
• B. Braun SE

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest News

Merit Medical Acquires Surfacer Inside-Out Access Catheter System from Bluegrass Vascular Technologies

• In June 2023, Merit Medical Systems, Inc., a prominent global healthcare technology company, revealed its acquisition of the Surfacer Inside-Out access catheter system from Bluegrass Vascular Technologies, Inc.

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.